BioSerenity is differentiated by its smartphone-sized portable EEG with integrated video monitoring, a form factor substantially smaller than competing ambulatory EEG systems, enabling home-based epilepsy and neurological monitoring. With FDA clearance, Series B funding, and a cloud-based diagnostic platform, it sits in the connected-diagnostics segment bridging wearable hardware and remote clinical review.